UVA-Developed Artificial Pancreas Effective for Children Ages 6 to 13, Study Finds
August 28, 2020
August 28, 2020
CHARLOTTESVILLE, Virginia, Aug. 28 -- The University of Virginia issued the following news release:
An artificial pancreas system, originally developed at the University of Virginia Center for Diabetes Technology, safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found.
Data from this and other studies (https://news.virginia.edu/content/artificial-pancreas-better-controls-blood-glucose-levels-c . . .
An artificial pancreas system, originally developed at the University of Virginia Center for Diabetes Technology, safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found.
Data from this and other studies (https://news.virginia.edu/content/artificial-pancreas-better-controls-blood-glucose-levels-c . . .